Cargando…

Risk Assessment for Cancer-Associated VTE: Diversifying the Evidence Base

[Figure: see text]

Detalles Bibliográficos
Autor principal:	Khorana, Alok A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627868/ https://www.ncbi.nlm.nih.gov/pubmed/36338160 http://dx.doi.org/10.1016/j.jacasi.2021.07.007

Ejemplares similares

Duration of anticoagulant therapy and VTE recurrence in patients with cancer
por: Khorana, Alok A., et al.
Publicado: (2019)

The risk of recurrent VTE and major bleeding in a commercially‐insured population of cancer patients treated with anticoagulation
por: Khorana, Alok A., et al.
Publicado: (2018)

VTE risk assessment in pregnancy
por: Ewins, Karl, et al.
Publicado: (2019)

Comparison of VTE risk scores in guidelines for VTE diagnosis in nonsurgical hospitalized patients with suspected VTE
por: Xiong, Wei, et al.
Publicado: (2023)

Assessing the risk of venous thromboembolism (VTE) in ambulatory patients with cancer: Rationale and implementation of a pharmacist-led VTE risk assessment program in an ambulatory cancer centre
por: Pelletier, Ryan
Publicado: (2021)

Predicting VTE in Cancer Patients: Candidate Biomarkers and Risk Assessment Models
por: Riondino, Silvia, et al.
Publicado: (2019)

Extended anticoagulation for VTE: what evidence justifies it?
por: Walia, Anushka, et al.
Publicado: (2023)

Are hospitals delivering appropriate VTE prevention? The venous thromboembolism study to assess the rate of thromboprophylaxis (VTE start)
por: Amin, A., et al.
Publicado: (2009)

Venous thromboembolism (VTE) risk assessment completion in psychiatric inpatients
por: Powell, Harriet, et al.
Publicado: (2021)

COVID-19 and Risk of VTE in Ethnically Diverse Populations
por: Go, Alan S., et al.
Publicado: (2021)

Audit cycle - VTE risk assessment in inpatient wards in mid Essex
por: Abdelkhalek, Hesham
Publicado: (2021)

VTE Risk assessment – a prognostic Model: BATER Cohort Study of young women
por: Heinemann, Lothar AJ, et al.
Publicado: (2005)

Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry stomach cancer subcohort
por: Yoshikawa, Takaki, et al.
Publicado: (2023)

Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review
por: van der Wall, Sake J., et al.
Publicado: (2018)

Evolving Treatment Options for Cancer-Related Venous Thromboembolism
por: Attia, Doaa, et al.
Publicado: (2020)

The Risk Factors of VTE and Survival Prognosis of Patients With Malignant Cancer: Implication for Nursing and Treatment
por: Qi, Yan, et al.
Publicado: (2020)

Challenges in Management of VTE in Children With Cancer: Risk Factors and Treatment Options
por: Samji, Nasrin, et al.
Publicado: (2022)

Incidence and risk factors for venous thromboembolism, bleeding, and death in colorectal cancer (Cancer‐VTE Registry)
por: Ikeda, Masataka, et al.
Publicado: (2022)

What’s new in VTE risk and prevention in orthopedic surgery
por: Kahn, Susan R., et al.
Publicado: (2020)

FRI428 VTE And Testosterone Therapy: What Is The Risk?
por: Cheatham, Callie, et al.
Publicado: (2023)

Sickle Cell Trait: Is There an Increased VTE Risk in Pregnancy and the Postpartum?
por: Pintova, Sofya, et al.
Publicado: (2013)

Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry pancreatic cancer subcohort
por: Okusaka, Takuji, et al.
Publicado: (2023)

Analysis of Readmissions Due to VTE—Using Hospital Data to Improve VTE Prophylaxis Compliance: A Quality Improvement Project
por: Hussain, Muzamil Hamid, et al.
Publicado: (2023)

Improving VTE risk assessment at point of admission to a tertiary centre cardiology ward
por: Wilson, Rachel
Publicado: (2015)

Venous thromboembolism (VTE) prophylaxis in severely injured patients: an international comparative assessment
por: Gunning, Amy C., et al.
Publicado: (2019)

Improving VTE risk assessment and prophylaxis prescribing rate in medical patients: integrating risk assessment tool into the workflow
por: Preston, Hannah, et al.
Publicado: (2020)

VTE in ICU Patients With COVID-19
por: Moll, Matthew, et al.
Publicado: (2020)

Systematic review of prognostic models for recurrent venous thromboembolism (VTE) post-treatment of first unprovoked VTE
por: Ensor, Joie, et al.
Publicado: (2016)

Molecular Correlates of Venous Thromboembolism (VTE) in Ovarian Cancer
por: Glassman, Deanna, et al.
Publicado: (2022)

VTE Prophylaxis Therapy: Clinical Practice vs Clinical Guidelines
por: Abukhalil, Abdallah Damin, et al.
Publicado: (2022)

Harmonizing hypercoagulable heterogeneity: Baseline VTE risk in COVID‐19
por: Goshua, George, et al.
Publicado: (2021)

Metabolomic Profile in Venous Thromboembolism (VTE)
por: Franczyk, Beata, et al.
Publicado: (2021)

CLOTTING AND COVID-19: IT IS NOT ALWAYS VTE
por: LINK, STEPHANIE L, et al.
Publicado: (2022)

Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score
por: de Winter, Maria A, et al.
Publicado: (2023)

Health care costs associated with venous thromboembolism in selected high-risk ambulatory patients with solid tumors undergoing chemotherapy in the United States
por: Khorana, Alok A, et al.
Publicado: (2013)

Using Clinical Vignettes to Evaluate VTE Protocol Adherence
por: Todoric, Krista, et al.
Publicado: (2012)

Bacteria diversify
por: Wells, William A.
Publicado: (2004)

VTE prophylaxis admission assessment full cycle audit and QI project
por: Drewniak, Krystyna, et al.
Publicado: (2021)

Clinicopathological Characteristics of Cancer-Associated Venous Thromboembolism (CAT-VTE) from a Medicolegal Autopsy
por: Ro, Ayako, et al.
Publicado: (2022)

Venous Thromboembolism in a Single Korean Trauma Center: Incidence, Risk Factors, and Assessing the Validity of VTE Diagnostic Tools
por: Boo, Sunjoo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dnqisk336e8d7mbe75seg0nl4g